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Function and Mechanism Studies on MTA1 gene 
In Invasion and Metastasis of Gastric Cancer 
 Abstract  
Background and Objective: The MTA1 product is a component of 
nuclear remodeling and deacetylation complex (NuRD), which regulates 
the gene transcription by altering the chromosin status. It has been 
reported that MTA1 is over-expressed in many types of cancer cells 
including gastric cancer. But the mechanism of MTA1 gene on the 
development of gastric cancer is unclear. The objective of this study is to 
investigate the influence of MTA1 gene on the malignant phnotype of 
human gastric cancer cell line BGC823. 
Metheds: In vitro, MTA1 gene was knockdown in the human gastric 
cancer line BGC823 by RNAi. On the other side, exogenous MTA1 gene 
was transfected to upregulate the expression of MTA1 gene in the human 
gastric cancer line BGC823. Then the influence of MTA1 gene on the 
malignant phnotype of the human gastric cancer cell line BGC823 was 
investigated by such methods as RT-PCR, Western blotting, colony 
formation. Boyden Chamber model was adopted to study the invasion 
and migration in vitro. To make clear the altered molecules by the 
expression change of MTA1 gene in the BGC823 cell line, RT-PCR 
analysis was performed. In vivo, the human gastric cancer of xenogrft 













was used to investigated the influence of MTA1 gene on the tumor 
formation.  
Results: The overexpression of MTA1 gene by transfection of exogenous 
MTA1 gene promoted the malignant phenotype of human gastric cancer 
cell BGC823, including the growth, colony information, invasion and 
migration. In contrast, the lower expression of MTA1 gene by 
transfection siRNA depressed the malignant phenotype of human gastric 
cancer cell BGC823, such as the growth, colony information, invasion 
and migration. It revealed that the expression of three 
metastasis-associated genes-integrin β1、cyclinD1、uPAR was changed 
with the expression change of MTA1 gene in the human gastric cancer 
cell line BGC823. The human gastric cancer of xenogrft model was 
established in athymic mice by subcutaneous injection. The cell line of 
BGC823 transfected MTA1-RNAi showed much less tumor formation, 
but the cell line of BGC823 transfected with the exogenous MTA1 gene 
showed more tumor formation.  
Conclusion: In this study, we found MTA1 gene broadly exert its 
affection on the down-stream gene expression and cellular biological 
behavior. MTA1 promotes the metastasis of gastric cancer cell BGC823 
and the general outcome of MTA1 RNAi is to reverse the malignant 
phenotype. According to our results from animal model, MTA1 is a 













effective beginning to explore metastasis mechanisms and cancer gene 
therapy strategy targeting MTA1.  
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